Novo Nordisk A/S (NVO) Earnings Date, Estimates & Call Transcripts $88.06 +4.33 (+5.16%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$88.10 +0.04 (+0.05%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Novo Nordisk A/S Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 1Before Market OpensEstimatedActual EPS (Feb. 5) $0.91 Beat By $0.03 Consensus EPS (Feb. 5) $0.88 Novo Nordisk A/S announced Q4 2024 earnings on February 5, 2025, reporting an EPS of $0.91, which topped the consensus estimate of $0.88 by $0.03. With a trailing EPS of $3.29 and a P/E Ratio of 26.77, Novo Nordisk A/S's earnings are expected to grow 21.35% next year, from $3.84 to $4.66 per share. Conference CallConference Call TranscriptNVO Upcoming EarningsNovo Nordisk A/S's next earnings date is estimated for Thursday, May 1, 2025, based off prior year's reporting schedules. Get Novo Nordisk A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novo Nordisk A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNVO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Novo Nordisk A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$3.84 EPSNext Year EPS Consensus Estimate: $4.66 EPS Novo Nordisk A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)-------2/5/2025Q4 2024$0.88$0.91+$0.03$0.91--8/7/2024Q2 2024$0.71$0.65 -$0.06$0.65$9.91B$9.82B5/2/2024Q1 2024$0.77$0.83+$0.06$0.83$9.23B$9.52B1/31/2024Q4 2023$0.66$0.71+$0.05$0.71$9.14B$9.51B11/2/2023Q3 2023$0.69$0.73+$0.04$0.73-$8.58B8/10/2023Q2 2023$0.3350$0.3150 -$0.02$1.26$8.44B$7.93B5/4/2023Q1 2023$0.3175$0.3175-$1.27$7.86B$7.69B Novo Nordisk A/S Earnings - Frequently Asked Questions When is Novo Nordisk A/S's earnings date? Novo Nordisk A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on NVO's earnings history. What guidance has Novo Nordisk A/S issued on next quarter's earnings? Novo Nordisk A/S updated its FY 2025 earnings guidance on Wednesday, February, 5th. The company issued revenue guidance of $49.4 billion-$53.6 billion, compared to the consensus revenue estimate of $47.6 billion. Did Novo Nordisk A/S beat their earnings estimates last quarter? In the previous quarter, Novo Nordisk A/S (NYSE:NVO) reported $0.91 earnings per share (EPS) to beat the analysts' consensus estimate of $0.88 by $0.03. Learn more on analysts' earnings estimate vs. NVO's actual earnings. How can I listen to Novo Nordisk A/S's earnings conference call? The conference call for Novo Nordisk A/S's latest earnings report can be listened to online. Listen to Conference Call How can I read Novo Nordisk A/S's conference call transcript? The conference call transcript for Novo Nordisk A/S's latest earnings report can be read online. Read Transcript How much revenue does Novo Nordisk A/S generate each year? Novo Nordisk A/S (NYSE:NVO) has a recorded annual revenue of $290.40 billion. How much profit does Novo Nordisk A/S generate each year? Novo Nordisk A/S (NYSE:NVO) has a recorded net income of $14.64 billion. NVO has generated $3.29 earnings per share over the last four quarters. What is Novo Nordisk A/S's price-to-earnings ratio? Novo Nordisk A/S (NYSE:NVO) has a trailing price-to-earnings ratio of 26.77 and a forward price-to-earnings ratio of 22.93. The price/earnings-to-growth ratio is 0.9. What is Novo Nordisk A/S's EPS forecast for next year? Novo Nordisk A/S's earnings are expected to grow from $3.84 per share to $4.66 per share in the next year, which is a 21.35% increase. More Earnings Resources from MarketBeat Related Companies AstraZeneca Earnings Results Novartis Earnings Results Sanofi Earnings Results GSK Earnings Results Takeda Pharmaceutical Earnings Results argenx Earnings Results BioNTech Earnings Results Teva Pharmaceutical Industries Earnings Results Summit Therapeutics Earnings Results Genmab A/S Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? This page (NYSE:NVO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVO Stock Alerts